When does CRESCITA THERAPEUTICS INC (CTX.CA) report earnings?
CRESCITA THERAPEUTICS INC (CTX.CA) will report earnings on 2026-05-13.
CRESCITA THERAPEUTICS INC (CTX.CA) Forecast, Price Target & Analyst Ratings
TSX:CTX • CA2258471028
Current stock price
0.75 CAD
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CRESCITA THERAPEUTICS INC (CTX.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.75 to mean target of N/A, Based on 0 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 17.522M -25.53% | 19.58M 11.75% | 21.118M 7.85% | |
| EBITDA YoY % growth | -450K -122.50% | -1.849M -310.89% | 479K 125.91% | |
| EBIT YoY % growth | -1.956M -469.06% | -3.215M -64.37% | -1.022M 68.21% | |
| Operating Margin | -11.16% | -16.42% | -4.84% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A